Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan and Memantine for Amphetamine Use Disorder
NCT04687566Phase 3Unknown
- Sponsor
- National Cheng Kung University Hospital
- Start
- Aug 2020
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dextromethorphan, memantine in amphetamine-type stimulant use disorder, sponsored by National Cheng Kung University Hospital. Status: unknown.
02
Drugs
dextromethorphanmemantine
03
Conditions
amphetamine-type stimulant use disorder
Beyond the preview
Go deeper on NCT04687566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04687566.